CDKL5 and postpartum depression: For example, AlloP was formulated and FDA-approved as a medicine for postpartum depression (Brexanolone®), and a 3β-methylated analogue of AlloP (Ganaxolone®) was FDA-approved for treatment of seizure associated with the rare disease cyclin-dependent kinase-like 5 deficiencies [10].